Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-03-25 Sale | 2024-08-14 4:05 pm | Q32 Bio Inc. | QTTB | TZIANABOS ARTHUR Director | 265 | $24.2 | $6,413 | 7,983 (Direct) | View |
| 2024-03-25 Sale | 2024-04-23 5:03 pm | Q32 Bio Inc. | QTTB | Alloway Paul See Remarks | 268 | $24.21 | $6,488 | 2,596 (Direct) | View |
| 2024-03-25 Sale | 2024-04-23 5:00 pm | Q32 Bio Inc. | QTTB | Michaud Charles Jr See Remarks | 75 | $24.2 | $1,815 | 927 (Direct) | View |
| 2024-01-09 Sale | 2024-02-15 4:33 pm | Homology Medicines Inc. | FIXX | TZIANABOS ARTHUR Director | 13,037 | $0.5711 | $7,445 | 148,498 (Direct) | View |
| 2024-01-03 Sale | 2024-01-05 5:54 pm | Homology Medicines Inc. | FIXX | Alloway Paul See Remarks | 7,280 | $0.566 | $4,120 | 28,036 (Direct) | View |
| 2024-01-03 Sale | 2024-01-05 5:49 pm | Homology Medicines Inc. | FIXX | Michaud Charles Jr See Remarks | 1,708 | $0.571 | $975 | 11,598 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-10-15 Exercise | 2024-10-16 8:39 pm | N/A N/A | Q32 Bio Inc. | QTTB | Violette Shelia M. Chief Scientific Officer | 6,000 | $7.29 | 93,042 (Direct) | View |
| 2024-10-11 Exercise | 2024-10-16 8:39 pm | N/A 2028-12-06 | Q32 Bio Inc. | QTTB | Violette Shelia M. Chief Scientific Officer | 10,574 | $0 | 93,042 (Direct) | View |
| 2024-10-11 Exercise | 2024-10-16 8:39 pm | N/A N/A | Q32 Bio Inc. | QTTB | Violette Shelia M. Chief Scientific Officer | 4,574 | $3.12 | 93,042 (Direct) | View |
| 2024-10-08 Exercise | 2024-10-10 4:05 pm | N/A 2028-12-06 | Q32 Bio Inc. | QTTB | Violette Shelia M. Chief Scientific Officer | 13,300 | $0 | 49,790 (Direct) | View |
| 2024-10-08 Exercise | 2024-10-10 4:05 pm | N/A N/A | Q32 Bio Inc. | QTTB | Violette Shelia M. Chief Scientific Officer | 13,300 | $3.12 | 49,790 (Direct) | View |
| 2024-04-01 Option Award | 2024-09-30 06:01 am | N/A 2034-03-31 | Q32 Bio Inc. | QTTB | Manke Isaac Director | 2,627 | $13.42 | 2,627 (Direct) | View |
| 2024-09-25 Option Award | 2024-09-27 9:57 pm | N/A 2034-09-24 | Q32 Bio Inc. | QTTB | Lundberg Sven Ante Director | 1,316 | $0 | 1,316 (Direct) | View |
| 2024-04-01 Option Award | 2024-08-14 4:05 pm | N/A 2034-03-31 | Q32 Bio Inc. | QTTB | GRAYZEL DAVID S. Director | 2,569 | $13.42 | 2,569 (Direct) | View |
| 2024-03-25 Exercise | 2024-08-14 4:05 pm | N/A N/A | Q32 Bio Inc. | QTTB | TZIANABOS ARTHUR Director | 1,095 | $0 | 7,983 (Direct) | View |
| 2024-03-25 Option Award | 2024-03-27 5:43 pm | N/A 2034-03-24 | Q32 Bio Inc. | QTTB | TZIANABOS ARTHUR Director | 12,767 | $0 | 12,767 (Direct) | View |
| 2024-03-25 Option Award | 2024-03-27 5:42 pm | N/A 2034-03-24 | Q32 Bio Inc. | QTTB | Manke Isaac Director | 12,767 | $0 | 12,767 (Direct) | View |
| 2024-03-25 Option Award | 2024-03-27 5:40 pm | N/A 2034-03-24 | Q32 Bio Inc. | QTTB | Iwicki Mark T Director | 25,534 | $0 | 25,534 (Direct) | View |
| 2024-03-25 Option Award | 2024-03-27 5:39 pm | N/A 2034-03-24 | Q32 Bio Inc. | QTTB | GRAYZEL DAVID S. Director | 12,767 | $0 | 12,767 (Direct) | View |
| 2024-03-25 Option Award | 2024-03-27 5:39 pm | N/A 2034-03-24 | Q32 Bio Inc. | QTTB | Xu Diyong Director 10% Owner | 12,767 | $0 | 12,767 (Direct) | View |
| 2024-03-25 Option Award | 2024-03-27 5:37 pm | N/A 2034-03-24 | Q32 Bio Inc. | QTTB | Campagna Jason Chief Medical Officer | 70,687 | $0 | 70,687 (Direct) | View |
| 2024-03-25 Option Award | 2024-03-27 5:36 pm | N/A 2034-03-24 | Q32 Bio Inc. | QTTB | Morrison Jodie Pope CEO | 394,445 | $0 | 394,445 (Direct) | View |
| 2024-03-25 Option Award | 2024-03-27 5:36 pm | N/A 2034-03-24 | Q32 Bio Inc. | QTTB | Violette Shelia M. Chief Scientific Officer | 56,413 | $0 | 56,413 (Direct) | View |
| 2024-03-25 Option Award | 2024-03-27 5:35 pm | N/A 2034-03-24 | Q32 Bio Inc. | QTTB | LAPORTE KATHLEEN Director | 12,767 | $0 | 12,767 (Direct) | View |
| 2024-03-25 Option Award | 2024-03-27 5:34 pm | N/A 2033-10-12 | Q32 Bio Inc. | QTTB | Kalowski Lee CFO and President | 161,323 | $0 | 161,323 (Direct) | View |
| 2024-03-25 Option Award | 2024-03-27 5:33 pm | N/A 2034-03-24 | Q32 Bio Inc. | QTTB | Thistle Mary Director | 12,767 | $0 | 12,767 (Direct) | View |
Ownership | 2024-03-27 5:32 pm | N/A N/A | Q32 Bio Inc. | QTTB | Violette Shelia M. Chief Scientific Officer | 0 | $0 | 123,853 (Indirect) | View |
| 2024-03-25 Option Award | 2024-03-27 5:25 pm | N/A 2034-03-24 | Q32 Bio Inc. | QTTB | Lundberg Sven Ante Director | 12,767 | $0 | 12,767 (Direct) | View |
Ownership | 2024-03-27 5:24 pm | N/A N/A | Q32 Bio Inc. | QTTB | GRAYZEL DAVID S. Director | 0 | $0 | 2,092,106 (Indirect) | View |
Ownership | 2024-03-27 5:23 pm | N/A N/A | Q32 Bio Inc. | QTTB | Xu Diyong Director 10% Owner | 0 | $0 | 2,252,987 (Indirect) | View |
Ownership | 2024-03-27 5:22 pm | N/A 2032-11-16 | Q32 Bio Inc. | QTTB | Morrison Jodie Pope CEO | 0 | $0 | 322,301 (Direct) | View |
Ownership | 2024-03-27 5:21 pm | N/A N/A | Q32 Bio Inc. | QTTB | LAPORTE KATHLEEN Director | 0 | $0 | 12,809 (Indirect) | View |
Ownership | 2024-03-27 5:20 pm | N/A 2031-03-24 | Q32 Bio Inc. | QTTB | Campagna Jason Chief Medical Officer | 0 | $0 | 105,689 (Direct) | View |
Ownership | 2024-03-27 5:18 pm | N/A 2033-11-08 | Q32 Bio Inc. | QTTB | Kalowski Lee CFO and President | 0 | $0 | 16,901 (Direct) | View |
Ownership | 2024-03-27 5:17 pm | N/A N/A | Q32 Bio Inc. | QTTB | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC Director 10% Owner | 0 | $0 | 2,252,987 (Indirect) | View |
Ownership | 2024-03-27 5:16 pm | N/A 2031-01-21 | Q32 Bio Inc. | QTTB | Iwicki Mark T Director | 0 | $0 | 44,837 (Direct) | View |
Ownership | 2024-03-27 5:16 pm | N/A N/A | Q32 Bio Inc. | QTTB | Atlas Venture Fund X L.P. ATLAS VENTURE ASSOCIATES X L.P. Atlas Venture Associates X LLC Atlas Venture Opportunity Fund I L.P. Atlas Venture Associates Opportunity I L.P. Atlas Venture Associates Opportunity I LLC Atlas Venture Opportunity Fund II L.P. Atlas Venture Associates Opportunity II LP Atlas Venture Associates Opportunity II LLC 10% Owner | 0 | $0 | 2,092,106 (Direct) | View |
Ownership | 2024-03-27 5:14 pm | N/A N/A | Q32 Bio Inc. | QTTB | Lundberg Sven Ante Director | 0 | $0 | 12,331 (Direct) | View |
| 2024-03-25 Exercise | 2024-03-27 4:15 pm | N/A N/A | Q32 Bio Inc. | FIXX | Alloway Paul See Remarks | 47,060 | $0 | 51,566 (Direct) | View |
| 2024-03-25 Exercise | 2024-03-27 4:15 pm | N/A N/A | Q32 Bio Inc. | FIXX | Michaud Charles Jr See Remarks | 12,896 | $0 | 18,046 (Direct) | View |
| 2024-01-01 Exercise | 2024-02-15 4:33 pm | N/A N/A | Homology Medicines Inc. | FIXX | TZIANABOS ARTHUR Director | 33,420 | $0 | 148,498 (Direct) | View |
| 2024-01-01 Exercise | 2024-01-03 4:15 pm | N/A N/A | Homology Medicines Inc. | FIXX | Alloway Paul See Remarks | 18,610 | $0 | 58,846 (Direct) | View |
| 2024-01-01 Exercise | 2024-01-03 4:15 pm | N/A N/A | Homology Medicines Inc. | FIXX | Michaud Charles Jr See Remarks | 4,240 | $0 | 19,754 (Direct) | View |
Ownership(A) | 2023-12-11 4:15 pm | N/A N/A | Homology Medicines Inc. | FIXX | Michaud Charles Jr See Remarks | 0 | $0 | 9,066 (Direct) | View |